Jaydip Biswas Selected Research

Tissue Inhibitor of Metalloproteinase-1

8/2015	A novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.
1/2013	Matrix metalloproteinase-9 as a potential tumor marker in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaydip Biswas Research Topics

Disease

37	Neoplasms (Cancer) 05/2017 - 07/2002
12	Carcinoma (Carcinomatosis) 10/2017 - 07/2006
11	Breast Neoplasms (Breast Cancer) 10/2017 - 07/2002
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2016 - 04/2011
5	Squamous Cell Carcinoma of Head and Neck 04/2017 - 02/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2017 - 01/2012
4	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 07/2006
4	Carcinogenesis 01/2014 - 03/2011
3	Ascites 05/2017 - 07/2006
3	Body Weight (Weight, Body) 05/2017 - 07/2006
3	Head and Neck Neoplasms (Head and Neck Cancer) 04/2017 - 01/2015
2	Adenocarcinoma 05/2017 - 01/2016
2	Leukemia 12/2016 - 01/2014
2	Neoplasm Metastasis (Metastasis) 10/2016 - 10/2013
2	Inflammation (Inflammations) 01/2016 - 07/2015
2	Melanoma (Melanoma, Malignant) 08/2015 - 11/2014
2	Uterine Cervical Dysplasia 07/2015 - 09/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2014 - 01/2012
1	Lymphoma (Lymphomas) 10/2017
1	Accidental Injuries 06/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Disease Progression 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2016

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 07/2017 - 02/2006
8	Pharmaceutical PreparationsIBA 12/2016 - 07/2006
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017 - 10/2011
6	Glycoproteins (Glycoprotein)IBA 01/2017 - 04/2011
6	CurcuminIBA 01/2014 - 01/2010
5	PhytochemicalsIBA 10/2017 - 10/2011
5	Proteins (Proteins, Gene)FDA Link 10/2017 - 12/2002
4	EnzymesIBA 01/2017 - 12/2002
4	AntioxidantsIBA 01/2017 - 08/2014
4	InterferonsIBA 01/2016 - 02/2006
4	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 02/2006
4	ArsenicIBA 04/2013 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 10/2017 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017 - 01/2012
3	Glutathione (Reduced Glutathione)IBA 03/2017 - 08/2014
3	Immunologic Factors (Immunomodulators)IBA 01/2017 - 01/2012
3	CopperIBA 12/2016 - 07/2006
3	Acetic Acid (Vinegar)FDA LinkGeneric 10/2016 - 09/2014
3	Carcinoembryonic AntigenIBA 09/2015 - 10/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2015 - 07/2002
3	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 10/2011
3	Hormones (Hormone)IBA 01/2013 - 07/2002
3	CytokinesIBA 09/2009 - 02/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 08/2015
2	lupeolIBA 04/2017 - 06/2016
2	PlatinumIBA 04/2017 - 01/2015
2	Estrogens (Estrogen)FDA Link 01/2017 - 07/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 01/2013
2	LigandsIBA 12/2016 - 01/2012
2	Annexin A5IBA 12/2016 - 07/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016 - 07/2006
2	TriterpenesIBA 06/2016 - 08/2015
2	Interferon-alpha (Interferon Alfa)IBA 01/2016 - 01/2015
2	VaccinesIBA 01/2016 - 10/2013
2	isothiocyanic acidIBA 01/2016 - 10/2012
2	Gemcitabine FDA Link 09/2015 - 07/2011
2	Monoclonal AntibodiesIBA 09/2015 - 10/2014
2	Tissue Inhibitor of Metalloproteinase-1IBA 08/2015 - 01/2013
2	Superoxide DismutaseIBA 07/2015 - 08/2014
2	Malondialdehyde (Propanedial)IBA 07/2015 - 08/2014
2	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2015 - 08/2014
2	CatalaseIBA 07/2015 - 08/2014
2	Glutathione PeroxidaseIBA 07/2015 - 08/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 10/2011
2	Immunoglobulin G (IgG)IBA 11/2014 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 12/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 12/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 10/2012
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 10/2012
2	Insulin (Novolin)FDA Link 12/2002 - 07/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2002 - 07/2002
1	Protein Kinases (Protein Kinase)IBA 10/2017
1	TeaIBA 10/2017
1	Vascular Endothelial Growth Factor BIBA 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2017
1	VanadiumIBA 05/2017
1	vanadium(III)-cysteineIBA 05/2017
1	ManganeseIBA 03/2017
1	Methylnitronitrosoguanidine (MNNG)IBA 03/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017
1	SeleniumIBA 01/2017
1	catalase-polyethylene glycolIBA 12/2016
1	Schiff Bases (Schiff Base)IBA 12/2016
1	ResveratrolIBA 10/2016

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 03/2017 - 09/2009
14	Therapeutics 01/2017 - 02/2006
8	Radiotherapy 01/2016 - 09/2009
4	Immunotherapy 01/2016 - 07/2006
3	Neoadjuvant Therapy 07/2017 - 01/2013
2	Induction Chemotherapy 01/2015 - 01/2015
2	Chemoradiotherapy 01/2015 - 07/2011
1	Operative Surgical Procedures 06/2017